Andrea Burnett-Hartman

Affiliate Instructor, Epidemiology


PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BPH Microbiology & Ecology, Miami University (Ohio), 2000


Kaiser Permanente
Seattle, WA
View Website »

Research Interests

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.

Recent Publications (PubMed)

Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large, Community-based Setting.
(2024 Feb 14)
Am J Gastroenterol
Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA

Dietary Factors Differ Between Young-Onset and Older-Onset Colorectal Cancer Patients.
(2024 Feb 12)
Nutr Cancer
Burnett-Hartman AN, Ton M, He Q, Malen RC, Potter JD, Reedy AM, Phipps AI, Newcomb PA

Colorectal cancer pre-diagnostic symptoms are associated with anatomic cancer site.
(2024 Feb 6)
BMC Gastroenterol 24(1): 65
Briggs NL, Ton M, Malen RC, Reedy AM, Cohen SA, Phipps AI, Burnett-Hartman AN, Newcomb PA

Maximizing scarce colonoscopy resources: the crucial role of Stool-Based tests.
(2024 Feb 4)
J Natl Cancer Inst
Coronado GD, Bienen L, Burnett-Hartman A, Lee JK, Rutter CM

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes.
(2024 Feb)
EBioMedicine 100(): 104977
Bull CJ, Hazelwood E, Legge DN, Corbin LJ, Richardson TG, Lee M, Yarmolinsky J, Smith-Byrne K, Hughes DA, Johansson M, Peters U, Berndt SI, Brenner H, Burnett-Hartman A, Cheng I, Kweon SS, Le Marchand L, Li L, Newcomb PA, Pearlman R, McConnachie A, Welsh P, Taylor R, Lean MEJ, Sattar N, Murphy N, Gunter MJ, Timpson NJ, Vincent EE

Show complete publication list

In the News

No news articles at this time.